Last $93.41 USD
Change Today -0.65 / -0.69%
Volume 2.0M
NVS On Other Exchanges
Symbol
Exchange
SIX Swiss Ex
Xetra
New York
OTC US
Mexico
Frankfurt
SIX Swiss Ex
As of 8:04 PM 09/23/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Harry Kirsch

Chief Financial Officer and Member of Executive Committee, Novartis AG
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

48SFr.2,520,106
As of Fiscal Year 2013

Background*

Mr. Harry Kirsch has been the Chief Financial Officer of Novartis AG since May 1, 2013. Mr. Kirsch joined Novartis in 2003 from Procter & Gamble. Mr. Kirsch studied industrial engineering and economics at the university of karlsruhe in Germany ("Diplom Wirtschaftsingenieur").

Corporate Headquarters*

Lichtstrasse 35
Basel, Basel-Stadt 4056

Switzerland

Phone: 41 61 324 11 11
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

Unknown/Other Education
Karlsruhe Institute of Technology

Other Affiliations*

Annual Compensation*

SalarySFr.483,333
BonusSFr.263,720
Total Annual CompensationSFr.747,053

Stock Options*

Restricted Stock AwardsSFr.1,659,522
All Other CompensationSFr.113,531
Total Number of Options44,569

Total Compensation*

Total Annual Cash CompensationSFr.860,584
Total Short Term CompensationSFr.747,053
Other Long Term CompensationSFr.1,773,053
Total Calculated CompensationSFr.2,520,106
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NVS:US $93.41 USD -0.65

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Alan George Lafley Chairman of the Board, Chief Executive Officer, President and Member of Proxy Committee
The Procter & Gamble Company
$6.4M
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
$1.8M
Kenneth C. Frazier Chairman and Chief Executive Officer
Merck & Co. Inc.
$1.5M
Severin Schwan Ph.D.Chief Executive Officer and Director
Roche Holding AG
SFr.5.1M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVARTIS AG-ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.